undamentalytics Newsletter

Bobo Donald E Jr: insider trades

Officer at Edwards Lifesciences. No open-market purchases and 25 sales not made under a pre-set plan, reported from May 11, 2010 to May 27, 2026.

What happened after Bobo Donald E Jr’s sales?

After their sales, the shares moved +8.3% against the index over 12 months on average (a negative figure means selling was the right call); 43% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Bobo Donald E Jr: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 25 +2.4% +1.5% 48% 10 0.37 0.72 No reliable evidence
Sales, 12 months after the report 21 +8.3% +4.3% 43% 8 0.67 0.52 No reliable evidence
Sales, 12 months after the trade 21 +9.0% +7.1% 43% 8 0.76 0.47 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Edwards Lifesciences EW CVP,Strategy/Corp Development025May 11, 2010May 27, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 27, 2026May 27, 2026 EW Sale $2,000,191 +2.2%not yetnot yet
May 18, 2026May 15, 2026 EW Sale $1,472,634 +7.2%not yetnot yet
February 26, 2026February 25, 2026 EW Sale $2,012,160 −10.6%not yetnot yet
December 12, 2025December 12, 2025 EW Sale $953,748 +1.6%not yetnot yet
May 8, 2023May 5, 2023 EW Sale $499,430 −21.0%−29.9%−30.4%
November 9, 2020November 6, 2020 EW Sale $46,101 −2.4%+13.5%+17.4%
August 31, 2020August 28, 2020 EW Sale $606,672 −6.6%+9.0%+9.1%
August 7, 2020August 6, 2020 EW Sale $927,360 −1.8%+13.8%+14.5%
November 6, 2019November 6, 2019 EW Sale $2,463,360 −12.0%−16.3%−17.3%
July 31, 2019July 29, 2019 EW Sale $4,450,266 +7.6%−3.6%−1.2%
May 30, 2019May 30, 2019 EW Sale $508,800 +22.1%+17.3%+20.9%
September 5, 2018August 31, 2018 EW Sale $10,818 +22.1%+49.0%+49.1%
May 24, 2018May 23, 2018 EW Sale $1,375,140 −1.9%+18.8%+16.4%
February 13, 2018February 12, 2018 EW Sale $478,275 +3.4%+31.7%+33.3%
August 8, 2017August 4, 2017 EW Sale $2,900,000 −15.3%+2.2%+7.1%
May 9, 2017May 5, 2017 EW Sale $2,107,547 +1.5%+8.1%+9.6%
February 28, 2012February 24, 2012 EW Sale $990,465 +20.7%+4.3%+3.0%
May 19, 2011May 18, 2011 EW Sale $339,009 −8.1%−5.7%−7.2%
May 16, 2011May 12, 2011 EW Sale $1,772,000 −12.8%−7.9%−7.6%
May 10, 2011May 9, 2011 EW Sale $194,073 −12.5%−7.8%−6.5%
March 1, 2011February 25, 2011 EW Sale $155,266 −2.2%−25.7%−20.7%
December 1, 2010November 30, 2010 EW Sale $483,584 +23.9%−5.0%−7.6%
November 24, 2010November 22, 2010 EW Sale $73,164 +16.3%−5.1%−5.8%
May 14, 2010May 13, 2010 EW Sale $1,265,375 +17.1%+56.4%+56.3%
May 11, 2010May 10, 2010 EW Sale $119,047 +20.3%+56.7%+56.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Bobo Donald E Jr traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.